Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Valeant’s Specialty Pharma COO Plans Departure | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Valeant’s Specialty Pharma COO Plans Departure

De Silva will stay on to lead Medicis integration efforts

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Rajiv De Silva, president and chief operating officer of Specialty Pharmaceuticals at Valeant Pharmaceuticals is leaving the company to pursue other interests. Mr. De Silva will remain with the company through the remainder of the year, when the integration planning efforts related to the Medicis Pharmaceutical acquisition are completed. Mr. De Silva will lead the integration planning efforts and it’s expected that a number of Medicis executives will accept positions with Valeant following the acquisition.
 
“The board and I appreciate the significant contributions Rajiv has made these past few years since joining me on this journey to create a new pharmaceutical operating model,” said J. Michael Pearson, chairman and chief executive officer. “Under Rajiv’s leadership, we have become a leader in the U.S. dermatology space and transformed our operations in Canada and Australia. And although his leadership will be missed, the company has created and developed a strong management team with Rajiv’s assistance that I am confident will lead us successfully through this transition period and into the future.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters